Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06003023 · ClinicalTrials.gov registry record · NA
Congenital Heart Disease Physical Activity Lifestyle Study V.2
A NA study of Heart Defects, Congenital and Cardiovascular Disease Other, sponsored by Jamie Jackson.
- Recruiting
- Registry status
- NA
- Development phase
- 144
- Enrollment target
- 1
- Study location
NCT06003023 is a NA study of Heart Defects, Congenital and Cardiovascular Disease Other that is actively recruiting participants, run by Jamie Jackson. The registered enrollment target is 144 participants, below the 348-participant average among 9 other Heart Defects, Congenital trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06003023, a NA study of Heart Defects, Congenital and Cardiovascular Disease Other, is actively recruiting participants, sponsored by Jamie Jackson.
- RECRUITING
- Registry status
- NA
- Development phase
- 144 participants
- Enrollment target
- 1
- Study location
Study Summary
The Congenital Heart Disease Physical Activity Lifestyle Intervention Study (CHD-PALS) V.2 seeks to determine the efficacy of a lifestyle intervention program for adolescents and young adults (AYAs) with congenital heart disease (CHD). This trial was adapted from the original CHD-PAL trial to continue improving cardiovascular outcomes for transition-aged CHD survivors.
Conditions Studied
Interventions
- BEHAVIORAL Physical Activity Monitoring
- BEHAVIORAL Tailored Exercise Prescription
- BEHAVIORAL Healthy Lifestyle Education
- BEHAVIORAL Physical Activity Lifestyle Intervention Informed by the Theory of Planned Behavior
Study Locations (1)
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2023-07-18 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06003023
The ClinicalTrials.gov registry entry for NCT06003023 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 348-participant average among 9 other Heart Defects, Congenital trials with a reported enrollment target (59% lower). The listed sponsor is Jamie Jackson, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Defects, Congenital appearing as the primary indexed condition, and to 4 interventions - of which Physical Activity Monitoring is the first listed.
NCT06003023 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06003023 about?
NCT06003023 is a clinical study titled "Congenital Heart Disease Physical Activity Lifestyle Study V.2". The Congenital Heart Disease Physical Activity Lifestyle Intervention Study (CHD-PALS) V.2 seeks to determine the efficacy of a lifestyle intervention program for adolescents and young adults (AYAs) with congenital heart disease (CHD). This trial was adapted from the original CHD-PAL trial to contin...
What is the current status of trial NCT06003023?
This trial is currently recruiting. It is a NA study. The enrollment target is 144 participants. The study started on 2023-07-18. Estimated completion is 2027-06-30.
What conditions does trial NCT06003023 study?
This clinical trial studies the following conditions: Heart Defects, Congenital, Cardiovascular Disease Other.
What interventions are being tested in trial NCT06003023?
The interventions under investigation include: Physical Activity Monitoring (BEHAVIORAL), Tailored Exercise Prescription (BEHAVIORAL), Healthy Lifestyle Education (BEHAVIORAL), Physical Activity Lifestyle Intervention Informed by the Theory of Planned Behavior (BEHAVIORAL).
Who is sponsoring clinical trial NCT06003023?
This trial is sponsored by Jamie Jackson, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06003023 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Defects, Congenital
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
HeartGPS: A Study Exploring the Effects of a Psychological Intervention for Parents and Their Babies After Prenatal Cardiac Diagnosis
RECRUITING · NA
-
Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD
ACTIVE NOT RECRUITING · NA
-
Evaluation of the GORE PV1 Device in Patients With Pulmonary Valve Dysfunction
ACTIVE NOT RECRUITING · NA
-
Tuning in to Kids: An Online, Group Program Tailored for Parents of Children With Congenital Heart Disease
COMPLETED · NA
-
SPECS: Safe Pediatric Euglycemia in Cardiac Surgery
COMPLETED · NA
-
Parent Communication for Feeding an Infant With a Heart Defect
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.